SHARILYN CHAPPELL

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant SEMINOLE, FL NPI 1477500684

General Payments — all program years on this page

$6,500.74

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 355
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $441.04 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $441.0421

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $225.2810
PFIZER INC. $85.914
Exact Sciences Corporation $52.133
Acerta Pharma LLC $35.922
Novo Nordisk AS $24.981
GlaxoSmithKline, LLC. $16.821

By program year

Program yearAmountRecords
2021 $2,228.38131
2022 $1,549.0587
2023 $2,282.27116
2024 $441.0421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100570570 Novo Nordisk Inc $24.98 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105353242 AstraZeneca Pharmaceuticals LP $15.12 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105831719 AstraZeneca Pharmaceuticals LP $20.80 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903984 ABBVIE INC. $9.25 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903986 ABBVIE INC. $31.23 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903988 ABBVIE INC. $33.48 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903990 ABBVIE INC. $8.77 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903992 ABBVIE INC. $32.39 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903994 ABBVIE INC. $30.71 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903996 ABBVIE INC. $28.68 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106903998 ABBVIE INC. $9.35 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106904000 ABBVIE INC. $15.87 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106904002 ABBVIE INC. $25.55 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114612586 Exact Sciences Corporation $15.72 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114612591 Exact Sciences Corporation $21.89 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114612594 Exact Sciences Corporation $14.52 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116286828 GlaxoSmithKline, LLC. $16.82 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130975313 PFIZER INC. $28.70 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131103228 PFIZER INC. $19.69 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131425882 PFIZER INC. $20.92 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132073562 PFIZER INC. $16.60 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.